Moriwaki H - Search Results

1

Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.

Goto N, Tsurumi H, Takemura M, Hara T, Sawada M, Kasahara S, Kanemura N, Yamada T, Shimizu M, Takahashi T, Tomita E, Seishima M, Takami T, Moriwaki H. Goto N, et al. Among authors: moriwaki h. Eur J Haematol. 2006 Sep;77(3):217-25. doi: 10.1111/j.1600-0609.2006.00702.x. Epub 2006 Jul 19. Eur J Haematol. 2006. PMID: 16856931

2

Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines.

Yasuda I, Shiratori Y, Adachi S, Obora A, Takemura M, Okuno M, Shidoji Y, Seishima M, Muto Y, Moriwaki H. Yasuda I, et al. Among authors: moriwaki h. J Hepatol. 2002 May;36(5):660-71. doi: 10.1016/s0168-8278(02)00044-2. J Hepatol. 2002. PMID: 11983450

3

Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor.

Kasahara S, Hara T, Itoh H, Ando K, Tsurumi H, Sawada M, Yamada T, Ohnishi H, Moriwaki H. Kasahara S, et al. Among authors: moriwaki h. Br J Haematol. 2002 Jul;118(1):181-8. doi: 10.1046/j.1365-2141.2002.03592.x. Br J Haematol. 2002. PMID: 12100146 Free article.

4

A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.

Sawada M, Tsurumi H, Yamada T, Hara T, Fukuno K, Goto H, Shimizu M, Kasahara S, Yoshikawa T, Kanemura N, Oyama M, Takami T, Moriwaki H. Sawada M, et al. Among authors: moriwaki h. Eur J Haematol. 2002 Jun;68(6):354-61. doi: 10.1034/j.1600-0609.2002.01654.x. Eur J Haematol. 2002. PMID: 12225393 Free article. Clinical Trial.

5

[Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].

Sawada M, Yamada T, Tsurumi H, Moriwaki H. Sawada M, et al. Among authors: moriwaki h. Rinsho Ketsueki. 2002 Nov;43(11):988-92. Rinsho Ketsueki. 2002. PMID: 12508484 Japanese.

6

Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes.

Kasahara S, Ando K, Saito K, Sekikawa K, Ito H, Ishikawa T, Ohnishi H, Seishima M, Kakumu S, Moriwaki H. Kasahara S, et al. Among authors: moriwaki h. J Virol. 2003 Feb;77(4):2469-76. doi: 10.1128/jvi.77.4.2469-2476.2003. J Virol. 2003. PMID: 12551985 Free PMC article.

7

Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.

Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. Kirii H, et al. Among authors: moriwaki h. Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):656-60. doi: 10.1161/01.ATV.0000064374.15232.C3. Epub 2003 Feb 27. Arterioscler Thromb Vasc Biol. 2003. PMID: 12615675

8

No involvement of beta-catenin gene mutation in gastric carcinomas induced by N-methyl-N-nitrosourea in male F344 rats.

Shimizu M, Suzui M, Moriwaki H, Mori H, Yoshimi N. Shimizu M, et al. Among authors: moriwaki h. Cancer Lett. 2003 Jun 10;195(2):147-52. doi: 10.1016/s0304-3835(03)00186-1. Cancer Lett. 2003. PMID: 12767522

9

Immunosuppressive therapy for myelodysplastic syndrome: efficacy of methylprednisolone pulse therapy with or without cyclosporin A.

Yamada T, Tsurumi H, Kasahara S, Hara T, Sawada M, Moriwaki H. Yamada T, et al. Among authors: moriwaki h. J Cancer Res Clin Oncol. 2003 Aug;129(8):485-91. doi: 10.1007/s00432-003-0477-z. Epub 2003 Jul 10. J Cancer Res Clin Oncol. 2003. PMID: 12856174 Free article.

10

Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration.

Fukushima H, Miwa Y, Ida E, Kuriyama S, Toda K, Shimomura Y, Sugiyama A, Sugihara J, Tomita E, Moriwaki H. Fukushima H, et al. Among authors: moriwaki h. JPEN J Parenter Enteral Nutr. 2003 Sep-Oct;27(5):315-22. doi: 10.1177/0148607103027005315. JPEN J Parenter Enteral Nutr. 2003. PMID: 12971730 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

893 results

Search Page

Filters